Connection
Marc Bonaca to Cost-Benefit Analysis
This is a "connection" page, showing publications Marc Bonaca has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.060 |
|
|
|
-
Magnuson EA, Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Braunwald E, Sabatine MS, Cohen DJ. Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial?Infarction: Analysis by Subgroups. J Am Coll Cardiol. 2018 01 02; 71(1):108.
Score: 0.031
-
Magnuson EA, Li H, Wang K, Vilain K, Shafiq A, Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Braunwald E, Sabatine MS, Cohen DJ. Cost-Effectiveness of Long-Term?Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial. J Am Coll Cardiol. 2017 Aug 01; 70(5):527-538.
Score: 0.030